GRI Bio Other Current Assets

GRI Bio (GRI) currently reports a other current assets of $230K as of April 2026. That compares with $650K in the prior-year period — down 64.4% year over year. Use the charts on this page to explore GRI Bio's other current assets history and peer comparisons.

GRI Bio's other current assets decreased from $650K to $230K — a 64.4% year-over-year decrease (period ending April 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GRI Bio reported $230K in other current assets as of April 2026. That compares with $650K in the prior-year period — down 64.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $230K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GRI Bio, and consider following GRI for alerts when major investors trade the stock.

GRI Bio is classified in the Healthcare sector. On other current assets, it currently shows $230K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GRI with unrelated industries.